Search Ontology:
ChEBI

BAY 73-6691

Term ID
CHEBI:231440
Synonyms
  • (R)-BAY 73-6691
  • (R)-BAY-73-6691
  • 1-(2-chlorophenyl)-1,5-dihydro-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-4H-pyrazolo[3,4-d]pyrimidin-4-one
  • 1-(2-chlorophenyl)-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
  • BAY 736691
  • BAY-73-6691
  • BAY736691
Definition
A member of the class of pyrazolopyrimidines that is 4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidine substituted by 2-chlorophenyl, oxo, and (2R)-3,3,3-trifluoro-2-methylpropyl groups at positions 1, 4 and 6, respectively. It is a potent and selective inhibitor of phosphodiesterase 9 (PDE9), currently in pre-clinical development for the treatment of Alzheimer's disease.
References
  • cas:794568-92-6
  • pubmed:16150925
  • pubmed:18674549
  • pubmed:22469131
  • pubmed:23034509
  • pubmed:26346295
  • pubmed:27071547
  • pubmed:29386424
  • pubmed:32826058
  • pubmed:38305876
  • wikipedia.en:BAY_73-6691
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from BAY 73-6691
Phenotype where environments contain BAY 73-6691
Phenotype modified by environments containing BAY 73-6691
Phenotype affecting BAY 73-6691
Human Disease Model